Medical Student. Faculty of Medicine, University of Porto. Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.
EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
BMC Infect Dis. 2018 Jul 6;18(1):309. doi: 10.1186/s12879-018-3221-7.
Antiretroviral therapy dramatically reduced HIV-related morbidity and mortality, prolonging the lifespan of HIV-infected patients. Greater duration of infection and exposure to antiretroviral therapy makes these patients susceptible to traditional cardio-metabolic risk factors and pathologies. The optimal diagnostic protocol for Diabetes Mellitus in these patients is still controversial. Haemoglobin A1c (HbA1c) has been shown to underestimate glycaemia levels and the oral glucose tolerance test (OGTT) has been shown to reveal cases of glucose metabolism disturbances in patients with normal fasting glucose. Thus, this study aimed to determine the prevalence of prediabetes and diabetes in a population of HIV-infected patients undergoing combined antiretroviral therapy, using three different diagnostic methods (fasting glucose, OGTT and HbA1c), to determine the agreement between the different methods and the characteristics associated with each one.
This study analyzed 220 HIV-infected patients on antiretroviral therapy. Patient characteristics were collected using a standardized protocol. Disturbances of glucose homeostasis were defined by the ADA 2017 criteria. Patients were characterized according to the presence or absence of clinical lipodystrophy, and distributed into four different categories, according to the presence, or absence of either clinical lipoatrophy, or abdominal prominence. Insulin resistance was assessed by HOMA-IR and QUICKI indexes. Agreement between the diagnostic methods was assessed by Cohen's kappa coefficient.
There were no patients diagnosed with diabetes with HbA1c. 5.9% prevalence was obtained when OGTT was used, and 3.2% prevalence when fasting glucose was used. Prediabetes had a prevalence of 14.1% when using HbA1c, 24.1% when using OGTT, and 20% when using fasting glucose. In all three methods, glucose homeostasis disturbances were associated with older age and higher resistance to insulin. Regarding other characteristics, associations varied between the three methods. The agreement between them was fair, or slight.
We observed that HbA1c was the method that diagnosed the least amount of cases and that OGTT was the one that diagnosed the most cases. Accordingly, our results indicate that HbA1c underestimated glycaemia levels in this population and that the use of OGTT might allow an earlier diagnosis of glucose homeostasis disturbances, potentially making it possible to avoid severe complications of DM.
抗逆转录病毒疗法显著降低了与 HIV 相关的发病率和死亡率,延长了 HIV 感染者的寿命。感染时间延长和接受抗逆转录病毒治疗使这些患者易患传统的心代谢危险因素和病理。这些患者的糖尿病最佳诊断方案仍存在争议。糖化血红蛋白 (HbA1c) 已被证明低估了血糖水平,口服葡萄糖耐量试验 (OGTT) 已被证明可发现空腹血糖正常的患者葡萄糖代谢紊乱的病例。因此,本研究旨在使用三种不同的诊断方法(空腹血糖、OGTT 和 HbA1c)确定接受联合抗逆转录病毒治疗的 HIV 感染患者中糖尿病前期和糖尿病的患病率,以确定不同方法之间的一致性,并确定与每种方法相关的特征。
本研究分析了 220 名接受抗逆转录病毒治疗的 HIV 感染患者。使用标准化方案收集患者特征。葡萄糖稳态紊乱根据 ADA 2017 标准定义。根据是否存在临床脂肪萎缩,将患者分为四个不同类别,并根据是否存在腹部突出或临床脂肪减少进行分类。胰岛素抵抗通过 HOMA-IR 和 QUICKI 指数评估。使用 Cohen's kappa 系数评估诊断方法之间的一致性。
HbA1c 未诊断出糖尿病患者。OGTT 检测的患病率为 5.9%,空腹血糖检测的患病率为 3.2%。使用 HbA1c 时,糖尿病前期的患病率为 14.1%,使用 OGTT 时为 24.1%,使用空腹血糖时为 20%。在所有三种方法中,葡萄糖稳态紊乱与年龄较大和胰岛素抵抗较高相关。关于其他特征,三种方法之间的关联不同。它们之间的一致性为适度或轻度。
我们观察到 HbA1c 是诊断病例最少的方法,而 OGTT 是诊断病例最多的方法。因此,我们的结果表明,HbA1c 低估了该人群的血糖水平,使用 OGTT 可能可以更早地诊断葡萄糖稳态紊乱,从而有可能避免 DM 的严重并发症。